BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $1,685,756 (100.0% shares, 0.0% debt)

Holdings (8)

STAA STAAR SURGICAL CO 50.7%

Value ($000) $855,207 Shares 10,795,348 Est. Cost $8.21 Unrealized +791.3%

MNST MONSTER BEVERAGE CORP NEW 25.5%

Value ($000) $430,632 Shares 4,656,488 Est. Cost $22.71 Unrealized +85.0%

IWM ISHARES TR 11.7%

Value ($000) $197,962 Shares 1,009,700 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 5.5%

Value ($000) $93,130 Shares 760,062 Est. Cost $27.50 Unrealized +317.2%

LCTX LINEAGE CELL THERAPEUTICS IN 3.6%

Value ($000) $59,849 Shares 34,005,379 Est. Cost $1.03 Unrealized +35.7%

— ONCOCYTE CORP 2.1%

Value ($000) $35,172 Shares 14,716,204 Est. Cost $3.13 Unrealized —

MNST MONSTER BEVERAGE CORP NEW 0.5%

Value ($000) $9,248 Shares 100,000 Est. Cost $22.71 Unrealized +85.0%

— AGEX THERAPEUTICS INC 0.3%

Value ($000) $4,556 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	10,795,348	$855,207	50.7%	$8.21	+791.3%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$430,632	25.5%	$22.71	+85.0%	COM	61174X109
IWM	ISHARES TR	1,009,700	$197,962	11.7%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$93,130	5.5%	$27.50	+317.2%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$59,849	3.6%	$1.03	+35.7%	COM	53566P109
—	ONCOCYTE CORP	14,716,204	$35,172	2.1%	$3.13	—	COM	68235C107
MNST	MONSTER BEVERAGE CORP NEW	100,000	$9,248	0.5%	$22.71	+85.0%	Put	61174X109
—	AGEX THERAPEUTICS INC	2,997,156	$4,556	0.3%	$2.99	—	COM	00848H108